3.0.0 1862 2025-12-05T21:54:24Z 2025-12-05T21:54:24Z Senate S S 2025-05-22 119 https://www.congress.gov/bill/119th-congress/senate-bill/1862 ssfi00 Finance Committee Senate Standing Referred To 2025-05-22T15:15:07Z 119 946 HR 2025-02-06 Sponsor introductory remarks on measure. (CR H535-536) Related bill CRS 2025-05-22 ssfi00 Finance Committee Senate Read twice and referred to the Committee on Finance. (text: CR S3119) IntroReferral 2025-05-22 Introduced in Senate IntroReferral 10000 9 Library of Congress B001261 Sen. Barrasso, John [R-WY] John Barrasso R WY N H001046 Sen. Heinrich, Martin [D-NM] Martin Heinrich D NM 2025-05-22 True Health Health 2025-06-13T13:42:46Z

00 2025-05-22 Introduced in Senate 2025-07-25T15:38:26Z <p><strong>Optimizing Research Progress Hope And New Cures Act or the ORPHAN Cures Act</strong></p><p>This bill modifies certain provisions under the Medicare Drug Price Negotiation Program with respect to orphan drugs.</p><p>The Medicare Drug Price Negotiation Program requires the Centers for Medicare &amp; Medicaid Services to negotiate the prices of certain prescription drugs under Medicare beginning in 2026. Among other requirements, drugs must have had market approval for at least 7 years (for drug products) or 11 years (for biologics) to qualify for negotiation. The program does not apply to orphan drugs that are approved to treat only one rare disease or condition.</p><p>The bill modifies these provisions so as to exclude any period in which a drug was an orphan drug from market approval calculations. It also excludes orphan drugs that are approved to treat more than one rare disease or condition from the program.</p>

Display Title 45 2025-06-04T03:23:27Z Short Title(s) as Introduced 101 2025-06-04T03:23:24Z Introduced in Senate IS Short Title(s) as Introduced 101 2025-06-04T03:23:24Z Introduced in Senate IS Official Title as Introduced 6 2025-06-04T03:18:22Z Introduced in Senate IS Introduced in Senate 2025-05-22T04:00:00Z https://www.govinfo.gov/content/pkg/BILLS-119s1862is/xml/BILLS-119s1862is.xml 2025-05-22 Read twice and referred to the Committee on Finance. (text: CR S3119) text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.